about
The role of purinergic receptors in cancer-induced bone painPurinergic signalling in boneHydraulic Pressure during Fluid Flow Regulates Purinergic Signaling and Cytoskeleton Organization of OsteoblastsMineral bone disorder in chronic kidney disease: head-to-head comparison of the 5/6 nephrectomy and adenine models.Reduced bone turnover in mice lacking the P2Y13 receptor of ADP.The purinergic receptor P2X5 regulates inflammasome activity and hyper-multinucleation of murine osteoclasts.P2Y2 receptors regulate osteoblast mechanosensitivity during fluid flow.Adenosine and bone metabolism.Altered bone development and an increase in FGF-23 expression in Enpp1(-/-) mice.Purinergic signalling: from discovery to current developments.Purinergic signaling is required for fluid shear stress-induced NF-κB translocation in osteoblastsDeficiency of the bone mineralization inhibitor NPP1 protects mice against obesity and diabetes.Caveolin-1 regulates P2X7 receptor signaling in osteoblastsExtracellular ATP released by osteoblasts is a key local inhibitor of bone mineralisation.Regulation of tenascin expression in bone.Transcriptional control mechanisms associated with the nucleotide receptor P2X7, a critical regulator of immunologic, osteogenic, and neurologic functions.CD73-generated adenosine promotes osteoblast differentiation.Characteristic expression of MSX1, MSX2, TBX2 and ENTPD1 in dental pulp cellsP2X7R-Panx1 Complex Impairs Bone Mechanosignaling under High Glucose Levels Associated with Type-1 DiabetesAssociation of P2Y(2) receptor SNPs with bone mineral density and osteoporosis risk in a cohort of Dutch fracture patientsAssociation of P2X7 receptor polymorphisms with bone mineral density and osteoporosis risk in a cohort of Dutch fracture patients.Extracellular purines promote the differentiation of human bone marrow-derived mesenchymal stem cells to the osteogenic and adipogenic lineages.Matrix-dependent adhesion mediates network responses to physiological stimulation of the osteocyte cell process.P2X7 nucleotide receptor signaling potentiates the Wnt/β-catenin pathway in cells of the osteoblast lineageIntroduction and perspective, historical note.c-Fos induction by gut hormones and extracellular ATP in osteoblastic-like cell lines.Selective induction of P2Y14 receptor by RANKL promotes osteoclast formation.Purinergic signalling in the musculoskeletal system.Purinergic signalling: Its unpopular beginning, its acceptance and its exciting future.Inflammation, pain, and pressure--purinergic signaling in oral tissues.ATP and arterial calcification.The role of P2Y₁₂ receptor and activated platelets during inflammation.Adenosine Triphosphate stimulates differentiation and mineralization in human osteoblast-like Saos-2 cells.A new perspective on mechanisms governing skeletal complications in type 1 diabetes.P2X₇-mediated calcium influx triggers a sustained, PI3K-dependent increase in metabolic acid production by osteoblast-like cells.Modeling Interactions among Individual P2 Receptors to Explain Complex Response Patterns over a Wide Range of ATP Concentrations.Stimulation of primary osteoblasts with ATP induces transient vinculin clustering at sites of high intracellular traction force.Dynamic redistribution of paxillin in bovine osteoblasts stimulated with adenosine 5'-triphosphate.Discovery of purinergic signalling, the initial resistance and current explosion of interest.Supplementation of exogenous adenosine 5'-triphosphate enhances mechanical properties of 3D cell-agarose constructs for cartilage tissue engineering
P2860
Q21284976-D2DBEA70-7AB3-4322-95D3-8B2306D36056Q27500363-853752AA-2E74-42B7-ABBB-677AEE93A88EQ33461851-25267D53-E629-4CED-A6ED-0DF8F1F1242BQ33580238-90A407CB-53E7-4790-9EAC-1A5DC2DDE0C9Q33636713-3697CC33-0297-4E58-BB5A-CBD5C2F6C5A8Q33669039-A20088B8-DC7D-4E3A-AF78-8545DB3502CAQ33701480-F5D37C68-70E3-44A0-8277-AC5D6FCC8D7CQ34036039-A8F1C1CC-2133-4B67-9DC6-D8EDB9F870E7Q34168605-3A97E8D0-073F-48AA-8817-3FCA99CEDF1CQ34400146-3AF6B5C7-87CD-46F3-ABD1-4D09FF12F64EQ34629041-A86A6006-7AF4-4978-930A-BA2795364AECQ34637356-DC1B8853-B71F-4D65-B408-3F76C13E4464Q34800820-A70BA713-F211-4A52-88A4-C47270D2A7FCQ34852675-49001084-BE8A-4304-9CAC-675C60A996B9Q35388360-2E49E491-13EB-4EFB-8DD7-DC3F93A19225Q35468810-C6612ED7-5055-4F43-92D6-B2191AD3CD07Q35612746-FF30F96E-4BD6-47F9-A716-93E8B9CEE28EQ35690311-476B2A96-438A-430B-849F-BD16724BBBF9Q36012130-A05D5086-3BAF-44BE-900D-D1559B7E476FQ36598554-EED5CA31-3D83-4DE4-AE65-533F69F0E01BQ36705634-367382C5-0A96-4B22-9FC8-0C53226FAD88Q36715918-EDD9EBD7-61A7-43DA-B6C4-C3498DD824C1Q37031872-8F8B0A34-D554-4217-A048-20928FE44ABAQ37256432-CDB2E74C-954A-451A-A514-0BB1EBB3DD01Q37330911-473D54E2-000F-4931-A547-2DED5A2A94EFQ37442047-EFE37315-94FE-43A2-A880-9C2298C97A92Q37462648-E6307ACF-8A77-4278-BDD5-14F07247AB64Q37468714-F62F0146-BA3B-463F-A715-8BDCBFFA74F6Q37975129-82C85464-462A-47D5-8D03-5E7AF3EF5A70Q38050028-543E6374-B49E-4CE8-9BB3-D7D4C50BF4B2Q38080569-8D0967AA-6891-46F5-AF0A-5AECB493021EQ38213187-2BFBC6F8-8A6F-4DF1-A3B0-0B4D3A734D63Q38770291-490E117C-23FC-4A0D-843A-56FE5852AD36Q38939772-910ABE32-8E25-4659-A003-1707EF7766ECQ39425060-6E0AFFD7-B5AD-4DAA-B3B9-FAC0610CE81CQ39550108-87C0CE16-53DA-4D8A-BA41-159E88C35C4FQ41892163-A181C5A2-E9E9-4741-83D8-4C38E1B83515Q41898760-F6AED2EE-D791-476F-B7ED-6F70381A8409Q41954765-5DE7CA01-ECC7-4104-9E84-B76350456990Q42020491-F3F24486-9CBD-4E2E-8972-A4356272FFFA
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Purinergic signalling and bone remodelling.
@ast
Purinergic signalling and bone remodelling.
@en
Purinergic signalling and bone remodelling.
@nl
type
label
Purinergic signalling and bone remodelling.
@ast
Purinergic signalling and bone remodelling.
@en
Purinergic signalling and bone remodelling.
@nl
prefLabel
Purinergic signalling and bone remodelling.
@ast
Purinergic signalling and bone remodelling.
@en
Purinergic signalling and bone remodelling.
@nl
P1476
Purinergic signalling and bone remodelling
@en
P2093
Geoffrey Burnstock
Timothy R Arnett
P304
P356
10.1016/J.COPH.2010.01.003
P577
2010-02-25T00:00:00Z